entertainment -WSS

entertainment

author：explore 2025-10-02 04:07:59 - browse：1

Parts of a DNA spotlighted -- Coverage from STAT — Adobe

Ring Therapeutics, a gene therapy startup launched by Flagship Pioneering, has laid off just under 20% of its staff, or 19 employees, Flagship confirmed to STAT.

The move comes as Sonata Therapeutics, another Flagship startup, has let go of a third of its staff, part of a broader hunkering down by platform companies. As funding for private biotechs remains scarce, startups hoping to develop new technologies — always an expensive, setback-ridden process — have had to make tough choices on staffing and priorities.

Ring had been particularly ambitious. The company is trying to engineer a new class of viruses as vehicles for delivering genes into patients’ cells. These viruses, tiny bugs called anelloviruses, had the potential to be safer and more versatile than the viruses currently used for gene therapy, called AAVs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Even great ERs can’t make up for American health disparities

focus

WSS

Commercial surrogacy can be ethical, despite pope’s claims

Congressmen charge Covid hearing ‘could have been an email’

Quicker fix for pulse oximeters urged during FDA public meeting

New Ultima Genomics DNA sequencer can read genome for $100

STAT Summit: Ending the crisis of Black deaths in the U.S.

Roche drug slashes death risk in early

Wikipedia

entertainment

hotspot

Drug repurposing or repositioning? The language matters

Congressmen charge Covid hearing ‘could have been an email’

BioMarin wins approval for gene therapy to treat hemophilia A

SAMSHA loosens regulations on methadone treatment centers

Novavax promises a turnaround & Lilly roils the obesity market

Woodcock on FDA’s accelerated approval and her next chapter

Virginia high school admissions case could be legal follow

STAT Summit: Meghan O’Rourke on making chronic illness visible

State Dept. review finds Biden bears some blame for Afghanistan failures

ADCs take center stage as promising cancer treatments

knowledge

The lessons of Aduhelm, an Alzheimer's drug that was not to be

STAT Readout Newsletter: Biotech news today

Juul spent big to court Black leaders to promote its e

Study on Amgen’s bispecific immunotherapy produces positive data

STAT Readout Newsletter: Biotech news today

Vertex non

leisure time

explore

focus

hotspot